Zusammenfassung
Die koronare Herzkrankheit (KHK) stellt eine häufige strukturelle Ursache für einen Herzstillstand im höheren Alter dar, während hierfür beim jungen Erwachsenen eher Kardiomyopathien oder Ionenkanalerkrankungen ursächlich sind. Strukturelle Herzerkrankungen sind bei etwa der Hälfte der Patienten mit Herzstillstand vorbekannt. Die vorliegende Übersichtsarbeit stellt aktuelle interventionelle und operative Therapiemöglichkeiten nach einem Herzstillstand dar. Schwerpunkte liegen hierbei auf der Darstellung der Zusammenhänge zwischen epidemiologischen Daten zur Inzidenz von malignen Herzrhythmusstörungen als Ursache für einen Herzstillstand in Abhängigkeit des Vorhandenseins einer KHK. Zum anderen wird der mögliche Nutzen einer möglichst frühen koronaren Revaskularisation und einer umgehenden kompletten Revaskularisation gegenüber der alleinigen Therapie der sog. „culprit lesion“ aufgezeigt. Abschließend werden die Vorteile invasiver Therapiemaßnahmen, wie etwa des zielgerichteten Temperaturmanagements und mechanischer Herzunterstützungssysteme für Patienten nach erfolgreich überstandener kardiopulmonaler Reanimation beschrieben. Letztere umfassen die sog. intraaortale Gegenpulsation (IABP) und Möglichkeiten der extrakorporalen Herzunterstützung („extracorporeal life support“, ECSL) zur peripheren und zentralen Unterstützung der rechten und linken Herzkammer.
Abstract
Coronary artery disease (CAD) represents a common structural cause for developing cardiac arrest in older patients, whereas in young adults cardiac arrest is more often caused by cardiomyopathies and cardiac channelopathies. A structural heart disease is known in almost 50% of patients prior to cardiac arrest. The present review outlines current interventional and operative therapeutic options for patients surviving cardiac arrest. The focus is on associations between epidemiological data on the incidence of malignant arrhythmias causing cardiac arrest depending on the presence or absence of CAD. Furthermore, the potential benefits of an early coronary revascularization as well as of a prompt complete coronary revascularization compared to the individual treatment of the so-called culprit lesion only are described. Finally, the advantages of invasive therapies for patients surviving cardiac arrest, such as targeted temperature management and mechanical cardiac assist devices, are elucidated. Cardiac assist devices comprise the use of the intra-aortic balloon pump (IABP) and devices for extracorporeal life support (ECLS) for peripheral and central support of the right and left heart chambers.
Literatur
Allen BS, Castella M, Buckberg GD et al (2003) Conditioned blood reperfusion markedly enhances neurologic recovery after prolonged cerebral ischemia. J Thorac Cardiovasc Surg 126:1851–1858
Authors/Task Force M, Windecker S, Kolh P et al (2014) 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35:2541–2619
Becker LB (2004) New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 61:461–470
Cronier P, Vignon P, Bouferrache K et al (2011) Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fibrillation. Crit Care 15:R122
Dae MW, Gao DW, Sessler DI et al (2002) Effect of endovascular cooling on myocardial temperature, infarct size, and cardiac output in human-sized pigs. Am J Physiol Heart Circ Physiol 282:H1584–H1591
De Waha S, Desch S, Fuernau G et al (2016) Interventional therapies in acute myocardial infarction complicated by cardiogenic shock. Herz. doi:10.1007/s00059-016-4511-8
Dumas F, Cariou A, Manzo-Silberman S et al (2010) Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry. Circ Cardiovasc Interv 3:200–207
Esposito ML, Shah N, Dow S et al (2016) Distinct effects of left or right atrial cannulation on left ventricular hemodynamics in a swine model of acute myocardial injury. ASAIO J 62:671–676
Farooq V, Serruys PW, Garcia-Garcia HM et al (2013) The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. J Am Coll Cardiol 61:282–294
Garcia S, Drexel T, Bekwelem W et al (2016) Early access to the cardiac catheterization laboratory for patients resuscitated from cardiac arrest due to a shockable rhythm: the Minnesota Resuscitation Consortium twin cities unified protocol. J Am Heart Assoc 5(1):e002670. doi:10.1161/JAHA.115.002670
Gorjup V, Radsel P, Kocjancic ST et al (2007) Acute ST-elevation myocardial infarction after successful cardiopulmonary resuscitation. Resuscitation 72:379–385
Hearse DJ, Humphrey SM, Chain EB (1973) Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol 5:395–407
Hess ML, Manson NH (1984) Molecular oxygen: friend and foe. The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. J Mol Cell Cardiol 16:969–985
Hochman JS, Sleeper LA, Webb JG et al (2006) Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 295:2511–2515
Hochman JS, Sleeper LA, Webb JG et al (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341:625–634
Hollenbeck RD, Mcpherson JA, Mooney MR et al (2014) Early cardiac catheterization is associated with improved survival in comatose survivors of cardiac arrest without STEMI. Resuscitation 85:88–95
Kapur NK, Paruchuri V, Majithia A et al (2015) Hemodynamic effects of standard versus larger-capacity intraaortic balloon counterpulsation pumps. J Invasive Cardiol 27:182–188
Kern KB, Hanna JM, Young HN et al (2016) Importance of both early reperfusion and therapeutic hypothermia in limiting myocardial infarct size post-cardiac arrest in a porcine model. JACC Cardiovasc Interv 9:2403–2412
Kim F, Nichol G, Maynard C et al (2014) Effect of prehospital induction of mild hypothermia on survival and neurological status among adults with cardiac arrest: a randomized clinical trial. JAMA 311:45–52
Liu W, Mukku VK, Gilani S et al (2013) Percutaneous Hemodynamic support (Impella) in patients with advanced heart failure and/or cardiogenic shock not eligible to PROTECT II trial. Int J Angiol 22:207–212
Maynard C, Longstreth WT Jr., Nichol G et al (2015) Effect of prehospital induction of mild hypothermia on 3‑month neurological status and 1‑year survival among adults with cardiac arrest: long-term follow-up of a randomized, clinical trial. J Am Heart Assoc 4:e001693
Mehta RH, Lopes RD, Ballotta A et al (2010) Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease? Am Heart J 159:141–147
Mooney MR, Unger BT, Boland LL et al (2011) Therapeutic hypothermia after out-of-hospital cardiac arrest: evaluation of a regional system to increase access to cooling. Circulation 124:206–214
Mukku VK, Cai Q, Gilani S et al (2012) Use of impella ventricular assist device in patients with severe coronary artery disease presenting with cardiac arrest. Int J Angiol 21:163–166
Murphy E, Steenbergen C (2008) Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 88:581–609
Nagao K, Hayashi N, Kanmatsuse K et al (2000) Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital. J Am Coll Cardiol 36:776–783
Nagao K, Kikushima K, Watanabe K et al (2010) Early induction of hypothermia during cardiac arrest improves neurological outcomes in patients with out-of-hospital cardiac arrest who undergo emergency cardiopulmonary bypass and percutaneous coronary intervention. Circ J 74:77–85
Nichol G, Guffey D, Stiell IG et al (2015) Post-discharge outcomes after resuscitation from out-of-hospital cardiac arrest: A ROC PRIMED substudy. Resuscitation 93:74–81
Nichol G, Karmy-Jones R, Salerno C et al (2006) Systematic review of percutaneous cardiopulmonary bypass for cardiac arrest or cardiogenic shock states. Resuscitation 70:381–394
Nielsen N, Wetterslev J, Cronberg T et al (2013) Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med 369:2197–2206
Nielsen N, Wetterslev J, Friberg H et al (2014) Targeted temperature management after cardiac arrest. N Engl J Med 370:1360
Noc M, Fajadet J, Lassen JF et al (2014) Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European association for percutaneous cardiovascular interventions (EAPCI)/stent for life (SFL) groups. EuroIntervention 10:31–37
Nolan JP, Soar J, Cariou A et al (2015) European Resuscitation Council and European Society of Intensive Care Medicine guidelines for post-resuscitation care 2015: section 5 of the European Resuscitation Council guidelines for resuscitation 2015. Resuscitation 95:202–222
O’neill WW, Kleiman NS, Moses J et al (2012) A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 126:1717–1727
Ouweneel DM, Eriksen E, Seyfarth M et al (2017) Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump for Treating Cardiogenic Shock: Meta-Analysis. J Am Coll Cardiol. 69(3):358–360
Ouweneel DM, Eriksen E, Sjauw KD et al (2017) Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol 69(3):278–287. doi:10.1016/j.jacc.2016.10.022
Ouweneel DM, Schotborgh JV, Limpens J et al (2016) Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Med 42:1922–1934
Patel MR, Smalling RW, Thiele H et al (2011) Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA 306:1329–1337
Patil KD, Halperin HR, Becker LB (2015) Cardiac arrest: resuscitation and reperfusion. Circ Res 116:2041–2049
Perk J, De Backer G, Gohlke H et al (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33:1635–1701
Priori SG, Blomstrom-Lundqvist C, Mazzanti A et al (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36:2793–2867
Rab T, Kern KB, Tamis-Holland JE et al (2015) Cardiac arrest: a treatment algorithm for emergent invasive cardiac procedures in the resuscitated comatose patient. J Am Coll Cardiol 66:62–73
Rihal CS, Naidu SS, Givertz MM et al (2015) 2015 SCAI/ACC/HFSA/STS Clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d’intervention. J Am Coll Cardiol 65:e7–e26
Sakamoto T, Morimura N, Nagao K et al (2014) Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with out-of-hospital cardiac arrest: a prospective observational study. Resuscitation 85:762–768
Schroeter MR, Kohler H, Wachter A et al (2016) Use of the impella device for acute coronary syndrome complicated by cardiogenic shock – experience from a single heart center with analysis of long-term mortality. J Invasive Cardiol 28:467–472
Sideris G, Magkoutis N, Sharma A et al (2014) Early coronary revascularization improves 24 h survival and neurological function after ischemic cardiac arrest. A randomized animal study. Resuscitation 85:292–298
Spaulding CM, Joly LM, Rosenberg A et al (1997) Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med 336:1629–1633
Steinberg C, Laksman ZW, Krahn AD (2016) Sudden cardiac death: a reappraisal. Trends Cardiovasc Med 26:709–719
Sunde K, Pytte M, Jacobsen D et al (2007) Implementation of a standardised treatment protocol for post resuscitation care after out-of-hospital cardiac arrest. Resuscitation 73:29–39
Takayama H, Truby L, Koekort M et al (2013) Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. J Heart Lung Transplant 32:106–111
Thiagarajan RR, Brogan TV, Scheurer MA et al (2009) Extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in adults. Ann Thorac Surg 87:778–785
Thiele H, Desch S, Piek JJ et al (2016) Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: design and rationale of CULPRIT-SHOCK trial. Am Heart J 172:160–169
Thiele H, Zeymer U, Neumann FJ et al (2013) Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 382:1638–1645
Thiele H, Zeymer U, Neumann FJ et al (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367:1287–1296
Vase H, Christensen S, Christiansen A et al (2016) The Impella CP device for acute mechanical circulatory support in refractory cardiac arrest. Resuscitation. doi:10.1016/j.resuscitation.2016.10.003
Wallentin L, Kristensen SD, Anderson JL et al (2014) How can we optimize the processes of care for acute coronary syndromes to improve outcomes? Am Heart J 168:622–631
Webb JG, Lowe AM, Sanborn TA et al (2003) Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol 42:1380–1386
Weisfeldt ML, Everson-Stewart S, Sitlani C et al (2011) Ventricular tachyarrhythmias after cardiac arrest in public versus at home. N Engl J Med 364:313–321
Yousuf O, Chrispin J, Tomaselli GF et al (2015) Clinical management and prevention of sudden cardiac death. Circ Res 116:2020–2040
Zelias A, Stepinska J, Andres J et al (2014) Ten-year experience of an invasive cardiology centre with out-of-hospital cardiac arrest patients admitted for urgent coronary angiography. Kardiol Pol 72:687–699
Zeymer U, Werdan K, Schuler G et al (2016) Impact of immediate multivessel percutaneous coronary intervention versus culprit lesion intervention on 1-year outcome in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the randomised IABP-SHOCK II trial. Eur Heart J Acute Cardiovasc Care. 2016. pii: 2048872616668977. doi:10.1177/2048872616668977
Danksagung
Wir danken den Firmen Abiomed Europe (Aachen, Germany), Cardiac Assisst, Inc. (Pittsburgh, USA), AVIDAL Group (Berlin, Germany) und MAQUET GETINGE GROUP (Rastatt, Germany) für die freundliche Bereitstellung der Abbildungen zu den Assist-Devices.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M. Behnes, K. Mashayekhi, M. Borggrefe und I. Akin geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Behnes, M., Mashayekhi, K., Borggrefe, M. et al. Koronare Herzerkrankung. Herz 42, 138–150 (2017). https://doi.org/10.1007/s00059-017-4546-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-017-4546-5